Cargando…
Nutrition and physical activity intervention for families with familial hypercholesterolaemia: protocol for a pilot randomised controlled feasibility study
BACKGROUND: Untreated heterozygous familial hypercholesterolaemia (FH) causes high low-density lipoprotein cholesterol (LDL-C) levels and increased cardiovascular disease (CVD) risk. Despite pharmacological treatment, many treated individuals remain at higher CVD risk than non-affected individuals....
Autores principales: | Kinnear, Fiona J., Hamilton-Shield, Julian P., Stensel, David J., Bayly, Graham, Searle, Aidan, Thackray, Alice E., Lithander, Fiona E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115059/ https://www.ncbi.nlm.nih.gov/pubmed/32266080 http://dx.doi.org/10.1186/s40814-020-00584-3 |
Ejemplares similares
-
Reducing cardiovascular disease risk among families with familial hypercholesterolaemia by improving diet and physical activity: a randomised controlled feasibility trial
por: Kinnear, Fiona Jane, et al.
Publicado: (2020) -
Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis
por: Kinnear, Fiona J, et al.
Publicado: (2019) -
How do the experiences and beliefs of adults and children with heterozygous familial hypercholesterolaemia influence their adherence to treatment? A systematic review of qualitative evidence protocol
por: Kinnear, Fiona J., et al.
Publicado: (2018) -
The development of a theory informed behaviour change intervention to improve adherence to dietary and physical activity treatment guidelines in individuals with familial hypercholesterolaemia (FH)
por: Kinnear, F. J., et al.
Publicado: (2020) -
Genetic Architecture of Familial Hypercholesterolaemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)